Business Today
Subscribe
PMS TodayBudget 2025US NewsIndiaWeatherBT ShortsNRIEducationElection
BT GolfBT India 100BT Mindrush
Search
Advertisement
Business News
markets
stocks
Nippon India NIFTY Pharma ETF Growth Plan
Nippon India NIFTY Pharma ETF Growth Plan

Nippon India NIFTY Pharma ETF Growth Plan (PHARMABEES) Share Price

  • Sector: ETF ()
  • Volume: 38,94,398
Dec 22, 2025
  • NSE
Share
  • Whatsapp
  • Twitter
  • Facebook
₹23.45
₹0.13 (0.56%)
22.80Low
Today’s Performance
23.90High
19.47Low
52 Week’s Performance
24.65High

bt_logoStock Analysis

bt_logoStock Performance

  • 1 Day0.56%
  • 1 Week0.90%
  • 1 Month1.82%
  • 3 Months2.31%
  • 6 Months6.45%
  • 1 Year2.09%
  • 3 Years21.76%
  • 5 Years10.11%

bt_logoStock Summary

  • Face Value (₹)10.00
  • Beta0.56
  • 52-Week Low (₹)12.22
  • 52-Week High (₹)20.80
  • Price-to-Book (X)*1.84
  • Dividend Yield (%)-
  • Price-to-Earnings (P/E) (X)*-
  • Earnings Per Share (₹)-
  • Market Cap (₹ Cr.)*639.01
* Values as of last close price

bt_logoCOMPETITORS

    BT TV

    India–New Zealand FTA Hits Roadblock as Coalition Partner Opposes Deal3:16India–New Zealand FTA Hits Roadblock As Coalition Partner Opposes Deal
    Silver's Powerful Run: How to Invest Amid Wild Swings | Ajay Kedia2:24Silver's Powerful Run: How To Invest Amid Wild Swings | Ajay Kedia
    Navi Mumbai Airport Exclusive: Jeet Adani On Launch & Sustainability | Jab We Met21:31Navi Mumbai Airport Exclusive: Jeet Adani On Launch & Sustainability | Jab We Met
    Jeet Adani On Gautam Adani’s Indomitable Spirit, Family Values & Life Beyond Headlines2:26Jeet Adani On Gautam Adani’s Indomitable Spirit, Family Values & Life Beyond Headlines
    Trump’s H-1B Crackdown Traps Indian Tech Workers As Apple, Google Warn: Don’t Travel4:32Trump’s H-1B Crackdown Traps Indian Tech Workers As Apple, Google Warn: Don’t Travel
    Gold, Silver, Copper After 2025’s Record Rally: What Lies Ahead In 2026?19:29Gold, Silver, Copper After 2025’s Record Rally: What Lies Ahead In 2026?
    Buying on Weakness: Where Value Is Emerging in Banks, Cement & Chemicals2:36Buying On Weakness: Where Value Is Emerging In Banks, Cement & Chemicals
    Rupee Breached 90/$: Why RBI Is Letting Markets Decide, Governor Explains4:04Rupee Breached 90/$: Why RBI Is Letting Markets Decide, Governor Explains
    RBI Cuts Rates by 125 bps Since Feb'25: Governor Explains What It Means for Growth and Loans4:20RBI Cuts Rates By 125 BPS Since Feb'25: Governor Explains What It Means For Growth And Loans
    PrashanthTapse Reveals 5 Santa Stocks & Brokerage Buzz | What's Hot26:32PrashanthTapse Reveals 5 Santa Stocks & Brokerage Buzz | What's Hot
    View more

    bt_logoFAQ's

    What was Nippon India NIFTY Pharma ETF Growth Plan share price previously?
    Nippon India NIFTY Pharma ETF Growth Plan share price was up by 0.56% from the previous closing price of ₹23.32.
    Who are peers of Nippon India NIFTY Pharma ETF Growth Plan?
    The peers of Nippon India NIFTY Pharma ETF Growth Plan are
    Who is/are the promoter/promoters of Nippon India NIFTY Pharma ETF Growth Plan?
    The promotor/promotors of Nippon India NIFTY Pharma ETF Growth Plan are
    What has been 52-week high of Nippon India NIFTY Pharma ETF Growth Plan stocks?
    The highest price of Nippon India NIFTY Pharma ETF Growth Plan stock is ₹24.65 in the last 52-week.
    What is the share price of Nippon India NIFTY Pharma ETF Growth Plan (PHARMABEES) today on NSE?
    As on Dec 22, 2025 Nippon India NIFTY Pharma ETF Growth Plan (PHARMABEES)’s share price on NSE is Rs 23.45
    What is the market cap of Nippon India NIFTY Pharma ETF Growth Plan (PHARMABEES)?
    The current market capitalisation of Nippon India NIFTY Pharma ETF Growth Plan (PHARMABEES) is 639.01 crores
    What is Nippon India NIFTY Pharma ETF Growth Plan Share symbol?
    The symbol of Nippon India NIFTY Pharma ETF Growth Plan is PHARMABEES.
    What is the PE ratio of Nippon India NIFTY Pharma ETF Growth Plan (PHARMABEES)?
    The current PE ratio of Nippon India NIFTY Pharma ETF Growth Plan (PHARMABEES) is -.
    What is the PB ratio of Nippon India NIFTY Pharma ETF Growth Plan (PHARMABEES)?
    The current PB ratio of Nippon India NIFTY Pharma ETF Growth Plan (PHARMABEES) is 1.84.
    Today’s High & Low share prices of Nippon India NIFTY Pharma ETF Growth Plan (PHARMABEES) on NSE?
    Today, the share price of Nippon India NIFTY Pharma ETF Growth Plan (PHARMABEES) on NSE touched a high of Rs 23.9 and a low of Rs 22.8
    What price did Nippon India NIFTY Pharma ETF Growth Plan (PHARMABEES) shares open on the NSE today?
    On NSE, the share price of Nippon India NIFTY Pharma ETF Growth Plan (PHARMABEES) opened at Rs 22.8
    What is the 52-week high of Nippon India NIFTY Pharma ETF Growth Plan (PHARMABEES)?
    The 52-week high price of Nippon India NIFTY Pharma ETF Growth Plan (PHARMABEES) is Rs 24.65
    What is the 52-week low of Nippon India NIFTY Pharma ETF Growth Plan (PHARMABEES)?
    The 52-week low price of Nippon India NIFTY Pharma ETF Growth Plan (PHARMABEES) is Rs 19.47

    bt_logoAbout Nippon India Nif

    Nippon India NIFTY Pharma ETF Growth Plan, incorporated in the year , has its registered office in 4th Floor Tower A Peninsula Bu, Ganapatrao Kadam Marg Lower Pa, Mumbai, Maharashtra, 400013, 91-22-6808 7000, 91-22-6808 7097. The main industry in which Nippon India NIFTY Pharma ETF Growth Plan operates is Stock Exchanges.

    Auditor/Auditors for Nippon India NIFTY Pharma ETF Growth Plan is/are . In the main management, is chairman and is the company secretary for Nippon India NIFTY Pharma ETF Growth Plan.

      bt_logoTop Stories

      DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

      DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

      By using this website, you agree to the Terms of Service and Privacy Policy.